The Haematology and Oncology department at Great Ormond Street Hospital operates as a unified cancer centre with University College Hospital London - forming the largest oncology centre in Europe. It is uniquely set up to treat the rarest and most complex forms of paediatric cancer and our overall haematology and oncology survival rates are comparable to the best results internationally.
The Oncology service treats patients with solid tumour cancers. We provide tertiary cancer care along the disease pathway and serve as the principal treatment centre for children diagnosed with a number of different malignant and non-malignant oncological diagnoses.
At GOSH we provide specialised services all under one roof for our international patients. The children and families are cared for by specialist nurses and doctors who are trained in cancer treatment and are able to provide help and advice to the families at all time and our main aim is to try and allow the families to have as much a normal life as possible.
In 2016/17, 146 operations for brain tumours took place at GOSH, of which 95% had no serious adverse events (grades 3-4).
The average success rate for low-intermediate risk neuroblastoma patients at GOSH is over 80%. The success rates within low risk patients is approximately 85% and intermediate risk patients approximately 75%. For high risk patients the survival rate at 3 years is 66% and at 5 years is 60%.
Conditions we treat
- Ewing’s sarcoma
- Hodgkin’s lymphoma
- Rhabdomyosarcoma and other soft tissue sarcomas
- Germ cell tumours as well as many other rare tumour types
- We also treat neuro-oncology conditions including astrocytoma, ependymoma, glioma and medulloblastoma